Tumor protein translationally controlled 1 is a p53 target gene that promotes cell survival

Cell Cycle

Volumn 12, Issue 14, 2013, Pages 2321-2328

  Chen, Weiming ^a,b,e   Wang, Huihui ^a   Tao, Shasha ^a   Zheng, Yi ^a   Wu, Wei ^a   Lian, Fangru ^c   Jaramillo, Melba ^a   Fang, Deyu ^b   Zhang, Donna D ^a,d  

^a UNIVERSITY OF ARIZONA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

^e Guangdong Provincial Academy of Chinese Medical Sciences   (China)

Author keywords

Cancer; P53; TCTP; Tpt1

Indexed keywords

HYDROGEN PEROXIDE; PROTEIN P53; TUMOR PROTEIN; TUMOR PROTEIN TRANSLATIONALLY CONTROLLED 1; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER REGRESSION; CANCER RESISTANCE; CANCER SURVIVAL; CARCINOGENESIS; CELL SURVIVAL; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; GENE EXPRESSION; GENE IDENTIFICATION; GENE INDUCTION; GENE TARGETING; LUNG PARENCHYMA; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROMOTER REGION; TRANSCRIPTION REGULATION; UPREGULATION; WILD TYPE;

EID: 84880408307     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.25404     Document Type: Article

References (26)

1. Brioudes F, Thierry AM, Chambrier P, Mollereau B, Bendahmane M. Translationally controlled tumor protein is a conserved mitotic growth integrator in animals and plants. Proc Natl Acad Sci USA 2010; 107:16384-9; PMID:20736351; http://dx.doi.org/10.1073/pnas.1007926107
2. Sanchez JC, Schaller D, Ravier F, Golaz O, Jaccoud S, Belet M, et al. Translationally controlled tumor protein: a protein identified in several nontumoral cells including erythrocytes. Electrophoresis 1997; 18:150-5; PMID:9059837; http://dx.doi.org/10.1002/elps.1150180127 (Pubitemid 27073664)
3. Chen SH, Wu PS, Chou CH, Yan YT, Liu H, Weng SY, et al. A knockout mouse approach reveals that TCTP functions as an essential factor for cell proliferation and survival in a tissue- or cell type-specific manner. Mol Biol Cell 2007; 18:2525-32; PMID:17475776; http://dx.doi.org/10.1091/mbc.E07-02-0188 (Pubitemid 47025718)
4. Gachet Y, Tournier S, Lee M, Lazaris-Karatzas A, Poulton T, Bommer UA. The growth-related, translationally controlled protein P23 has properties of a tubulin binding protein and associates transiently with microtubules during the cell cycle. J Cell Sci 1999; 112:1257-71; PMID:10085260 (Pubitemid 29218914)
5. Kim M, Jung Y, Lee K, Kim C. Identification of the calcium binding sites in translationally controlled tumor protein. Arch Pharm Res 2000; 23:633-6; PMID:11156187; http://dx.doi.org/10.1007/BF02975253
6. Demidenko ZN, Korotchkina LG, Gudkov AV, Blagosklonny MV. Paradoxical suppression of cellular senescence by p53. Proc Natl Acad Sci USA 2010; 107:9660-4; PMID:20457898; http://dx.doi.org/10.1073/pnas.1002298107
7. Johansson H, Vizlin-Hodzic D, Simonsson T, Simonsson S. Translationally controlled tumor protein interacts with nucleophosmin during mitosis in ES cells. Cell Cycle 2010; 9:2160-9; PMID:20505363; http://dx.doi.org/10.4161/cc.9. 11.11841
8. Gnanasekar M, Dakshinamoorthy G, Ramaswamy K. Translationally controlled tumor protein is a novel heat shock protein with chaperone-like activity. Biochem Biophys Res Commun 2009; 386:333-7; PMID:19523440; http://dx.doi.org/10. 1016/j.bbrc.2009.06.028
9. Lucibello M, Gambacurta A, Zonfrillo M, Pierimarchi P, Serafino A, Rasi G, et al. TCTP is a critical survival factor that protects cancer cells from oxidative stressinduced cell-death. Exp Cell Res 2011; 317:2479-89; PMID:21801721; http://dx.doi.org/10.1016/j.yexcr.2011.07.012
10. Gnanasekar M, Thirugnanam S, Zheng G, Chen A, Ramaswamy K. Gene silencing of translationally controlled tumor protein (TCTP) by siRNA inhibits cell growth and induces apoptosis of human prostate cancer cells. Int J Oncol 2009; 34:1241-6; PMID:19360337
11. Liu H, Peng HW, Cheng YS, Yuan HS, Yang-Yen HF. Stabilization and enhancement of the antiapoptotic activity of mcl-1 by TCTP. Mol Cell Biol 2005; 25:3117-26; PMID:15798198; http://dx.doi.org/10.1128/MCB.25.8.3117-3126.2005 (Pubitemid 40464314)
12. Ma Q, Geng Y, Xu W, Wu Y, He F, Shu W, et al. The role of translationally controlled tumor protein in tumor growth and metastasis of colon adenocarcinoma cells. J Proteome Res 2010; 9:40-9; PMID:19621893; http://dx.doi.org/10.1021/ pr9001367
13. Telerman A, Amson R. The molecular programme of tumour reversion: the steps beyond malignant transformation. Nat Rev Cancer 2009; 9:206-16; PMID:19180095; http://dx.doi.org/10.1038/nrc2589
14. Tuynder M, Fiucci G, Prieur S, Lespagnol A, Géant A, Beaucourt S, et al. Translationally controlled tumor protein is a target of tumor reversion. Proc Natl Acad Sci USA 2004; 101:15364-9; PMID:15489264; http://dx.doi.org/10. 1073/pnas.0406776101 (Pubitemid 39441547)
15. Tuynder M, Susini L, Prieur S, Besse S, Fiucci G, Amson R, et al. Biological models and genes of tumor reversion: cellular reprogramming through tpt1/TCTP and SIAH-1. Proc Natl Acad Sci USA 2002; 99:14976-81; PMID:12399545; http://dx.doi.org/10.1073/pnas.222470799 (Pubitemid 35334595)
16. Li F, Zhang D, Fujise K. Characterization of fortilin, a novel antiapoptotic protein. J Biol Chem 2001; 276:47542-9; PMID:11598139; http://dx.doi.org/10.1074/jbc.M108954200
17. Chen W, Sun Z, Wang XJ, Jiang T, Huang Z, Fang D, et al. Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response. Mol Cell 2009; 34:663-73; PMID:19560419; http://dx.doi.org/10.1016/j.molcel.2009.04.029
18. Rotblat B, Melino G, Knight RA. NRF2 and p53: Januses in cancer? Oncotarget 2012; 3:1272-83; PMID:23174755
19. Cano CE, Gommeaux J, Pietri S, Culcasi M, Garcia S, Seux M, et al. Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function. Cancer Res 2009; 69:219-26; PMID:19118006; http://dx.doi.org/10.1158/ 0008-5472.CAN-08-2320
20. Zhang Y, Qian Y, Lu W, Chen X. The G proteincoupled receptor 87 is necessary for p53-dependent cell survival in response to genotoxic stress. Cancer Res 2009; 69:6049-56; PMID:19602589; http://dx.doi.org/10.1158/0008-5472. CAN-09-0621
21. Zhang Y, Shu L, Chen X. Syntaxin 6, a regulator of the protein trafficking machinery and a target of the p53 family, is required for cell adhesion and survival. J Biol Chem 2008; 283:30689-98; PMID:18779328; http://dx.doi.org/10.1074/jbc.M801711200
22. Feng X, Liu X, Zhang W, Xiao W. p53 directly suppresses BNIP3 expression to protect against hypoxia-induced cell death. EMBO J 2011; 30:3397-415; PMID:21792176; http://dx.doi.org/10.1038/emboj.2011.248
23. Rho SB, Lee JH, Park MS, Byun HJ, Kang S, Seo SS, et al. Anti-apoptotic protein TCTP controls the stability of the tumor suppressor p53. FEBS Lett 2011; 585:29-35; PMID:21081126; http://dx.doi.org/10.1016/j.febslet.2010.11.014
24. Amson R, Pece S, Lespagnol A, Vyas R, Mazzarol G, Tosoni D, et al. Reciprocal repression between P53 and TCTP. Nat Med 2012; 18:91-9; PMID:22157679; http://dx.doi.org/10.1038/nm.2546
25. Sun Y, Yi H, Zhang PF, Li MY, Li C, Li F, et al. Identification of differential proteins in nasopharyngeal carcinoma cells with p53 silence by proteome analysis. FEBS Lett 2007; 581:131-9; PMID:17184779; http://dx.doi.org/10.1016/j.febslet.2006.12.008 (Pubitemid 44960291)
26. Zheng H, Whitman SA, Wu W, Wondrak GT, Wong PK, Fang D, et al. Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy. Diabetes 2011; 60:3055-66; PMID:22025779; http://dx.doi.org/10. 2337/db11-0807